Former FDA Comissioner Mark McClellan Talks About I-SPY 2

Bio Century TV Webcast examines the need for regulatory reform to speed up drug development.

BioCentury This Week opens an important dialog on “Regulatory Innovation” in its Sunday, Nov. 28 broadcast, devoting the entire program to a conversation with Dr. Mark McClellan, Director of the Engelberg Center for Health Care Reform at the Brookings Institution, and the only person to head both FDA and Medicare. Dr. McClellan discusses obstacles in the current clinical trials process, and the resulting obstacles for drugs reaching patients in a timely and cost-effective manner.

"Dr. McClellan specifically highlights the I-SPY2 Clinical Trial as a leading example of the type of regulatory reform necessary to move the industry forward."

The program can be viewed Here